PIP breast implant affair highlights shortfalls in EU regulatory system
This article was originally published in SRA
Executive Summary
The public health scare in the EU and beyond caused by substandard Poly Implante Prosthèse breast implants has as much to do with the largely unregulated private cosmetic surgery industry, the actions of a rogue manufacturer and the global nature of business as it does with the regulation of the medical device industry.